NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA
Clinical trials for NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA trials appear
Sign up with your email to follow new studies for NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to tame high cholesterol
Disease control Not yet recruitingThis study is testing a new injectable drug called SYH2053 to see if it safely lowers 'bad' cholesterol (LDL-C) in adults with high cholesterol or mixed lipid problems. It will compare the drug against a placebo (dummy injection) in 760 participants over about a year. The main go…
Matched conditions: NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New shot aims to zap bad cholesterol
Disease control Not yet recruitingThis study is testing a new injectable drug called IBI306 to see if it safely lowers 'bad' LDL cholesterol in adults with high cholesterol and mixed lipid levels. About 198 participants will be randomly assigned to receive either the real drug or a placebo (dummy) injection for 1…
Matched conditions: NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New shot aims to tame stubborn high cholesterol
Disease control Not yet recruitingThis study is testing a new injectable drug called SYH2053 for people with high cholesterol that isn't well controlled by their current medications. It will enroll 900 adults to see if the injection safely lowers 'bad' LDL cholesterol more effectively than a placebo shot. The goa…
Matched conditions: NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC